GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

NTRB · Oct 31, 2024

NutriBand Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001213900-24-105201General Corporate
Revenue growth67thOwn-history percentile · N=18
Evidence method

Yoy · gp.fundamentals.revenue

50.94% · CORE · VALID

Inventory pressure47thOwn-history percentile · N=17
Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

26.06% · OPTIONAL · VALID

Gross margin25thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.gross_margin

29.58% · CORE · VALID

Operating margin60thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.operating_margin

-220.94% · CORE · VALID

R&D intensity78thOwn-history percentile · N=9
Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

136.38% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History29 statesHistory building
Period transition

What moved in the state?

Growth Increased
Previous
-32.49%
Current
50.94%
Delta
83.43%
Inventory Pressure Decreased
Previous
50.55%
Current
26.06%
Delta
-24.49%
Margin Increased
Previous
22.93%
Current
29.58%
Delta
6.65%
Profitability Increased
Previous
-318.35%
Current
-220.94%
Delta
97.41%
R And D Intensity Decreased
Previous
174.78%
Current
136.38%
Delta
-38.39%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.